journal cover

AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies

Annals of Neurology

Nov 20, 2016

Kejal KantarciRonald C Petersen

Abstract

Patients with probable dementia with Lewy bodies (DLB) often have Alzheimer's disease (AD)-related pathology. Our objective was to determine the pattern of positron emission tomography (PET) tau tracer AV-1451 uptake in patients with probable DLB, compared to AD, and its relationship to...read more

Mentioned in this Paper

N-methyl-(11C)2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
Familial Alzheimer Disease (FAD)
4-iodobenzenesulfonamide
Patterns
Adrenal Cortex Diseases
Occipital Lobe
APP protein, human
Magnetic Resonance Imaging
Positron-Emission Tomography
TFF3
1
1
82
Paper Details
References
  • References31
  • Citations30
1234
  • References31
  • Citations30
123

Similar Papers Found In These Feeds

Tau Aggregation: Genomics

Tau Aggregation is an important characteristic in some neurodegenerative disorders, including Alzheimer’s Disease. Discover the latest research using genomics to understand Tau Aggregation.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's Disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's Disease here.

Alzheimer's Disease: Neuroimaging

Alzheimer's disease (AD) is a chronic neurodegenerative disease. Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Tauopathies

Tauopathies are neurodegenerative disorders caused due to misfolding and aggregation of the tau protein in neurofibrillary tangles in the brain. Discover the latest research on tauopathies here.

Alzheimer's Disease: Abeta

Alzheimer's disease (AD) is a chronic neurodegenerative disease associated with accumulation of amyloid plaques, which are comprised of amyloid beta. Here is the latest research in this field.

Lewy Body Disease

Lewy Body Disease, associated with abnormal deposits of proteins like alpha-synuclein in the brain, causes a decline in mental abilities. Here is the latest on this progressive neurological disorder.

Frontotemporal Dementia

Frontotemporal dementia (FTD) refers to disorders caused by progressive neuronal loss in the frontal and temporal lobes of the brain. Here is the latest research on FTD and FTD-associated disorders.

Alzheimer's Disease: APP

Amyloid precursor protein proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques. Here is the latest research.

Cognitive Decline: Environmental And Genetic Factors

This feed focuses on the role of environmental and genetic factors including environmental policies, disease susceptibility, and socioeconomic status on cognitive decline. Here is the latest research.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a chronic neurodegenerative disease. This feed focuses on the underlying role of Tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's.

Brain Aging

Here is the latest research on intrinsic and extrinsic factors, as well as pathways and mechanisms that underlie aging in the central nervous system.

Related Papers

Annals of Neurology

Tau positron emission tomographic imaging in aging and early Alzheimer disease

Annals of NeurologyOctober 28, 2015
Keith A JohnsonReisa Sperling
Neurobiology of Aging

Multimodality imaging characteristics of dementia with Lewy bodies

Neurobiology of AgingOctober 25, 2011
Kejal KantarciClifford R Jack
© 2020 Meta ULC. All rights reserved

AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies

Annals of Neurology

Nov 20, 2016

Kejal KantarciRonald C Petersen

PMID: 27863444

DOI: 10.1002/ana.24825

Abstract

Patients with probable dementia with Lewy bodies (DLB) often have Alzheimer's disease (AD)-related pathology. Our objective was to determine the pattern of positron emission tomography (PET) tau tracer AV-1451 uptake in patients with probable DLB, compared to AD, and its relationship to...read more

Mentioned in this Paper

N-methyl-(11C)2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
Familial Alzheimer Disease (FAD)
4-iodobenzenesulfonamide
Patterns
Adrenal Cortex Diseases
Occipital Lobe
APP protein, human
Magnetic Resonance Imaging
Positron-Emission Tomography
TFF3
1
1
82

Similar Papers Found In These Feeds

Tau Aggregation: Genomics

Tau Aggregation is an important characteristic in some neurodegenerative disorders, including Alzheimer’s Disease. Discover the latest research using genomics to understand Tau Aggregation.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's Disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's Disease here.

Related Papers

Annals of Neurology

Tau positron emission tomographic imaging in aging and early Alzheimer disease

Annals of NeurologyOctober 28, 2015
Keith A JohnsonReisa Sperling
Neurobiology of Aging

Multimodality imaging characteristics of dementia with Lewy bodies

Neurobiology of AgingOctober 25, 2011
Kejal KantarciClifford R Jack
Paper Details
References
  • References31
  • Citations30
1234
  • References31
  • Citations30
123
/papers/av-1451-tau-and--amyloid-positron-emission/27863444